img

Global Advanced Therapy Based on Gene Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Advanced Therapy Based on Gene Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Advanced Therapy Based on Gene report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Advanced Therapy Based on Gene market is projected to reach US$ 34850 million in 2033, increasing from US$ 9063 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2033. Demand from Neurological Diseases and Cancer are the major drivers for the industry.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Advanced Therapy Based on Gene market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral
Non-viral

Segment by Application


Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Advanced Therapy Based on Gene market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Advanced Therapy Based on Gene introduction, etc. Advanced Therapy Based on Gene Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Advanced Therapy Based on Gene market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Advanced Therapy Based on Gene
1.1 Advanced Therapy Based on Gene Market Overview
1.1.1 Advanced Therapy Based on Gene Product Scope
1.1.2 Advanced Therapy Based on Gene Market Status and Outlook
1.2 Global Advanced Therapy Based on Gene Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Advanced Therapy Based on Gene Market Size by Region (2018-2033)
1.4 Global Advanced Therapy Based on Gene Historic Market Size by Region (2018-2023)
1.5 Global Advanced Therapy Based on Gene Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Advanced Therapy Based on Gene Market Size (2018-2033)
1.6.1 North America Advanced Therapy Based on Gene Market Size (2018-2033)
1.6.2 Europe Advanced Therapy Based on Gene Market Size (2018-2033)
1.6.3 Asia-Pacific Advanced Therapy Based on Gene Market Size (2018-2033)
1.6.4 Latin America Advanced Therapy Based on Gene Market Size (2018-2033)
1.6.5 Middle East & Africa Advanced Therapy Based on Gene Market Size (2018-2033)
2 Advanced Therapy Based on Gene Market by Type
2.1 Introduction
2.1.1 Viral
2.1.2 Non-viral
2.2 Global Advanced Therapy Based on Gene Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Advanced Therapy Based on Gene Historic Market Size by Type (2018-2023)
2.2.2 Global Advanced Therapy Based on Gene Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Advanced Therapy Based on Gene Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Advanced Therapy Based on Gene Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Advanced Therapy Based on Gene Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Advanced Therapy Based on Gene Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Advanced Therapy Based on Gene Revenue Breakdown by Type (2018-2033)
3 Advanced Therapy Based on Gene Market Overview by Application
3.1 Introduction
3.1.1 Neurological Diseases
3.1.2 Cancer
3.1.3 Other
3.2 Global Advanced Therapy Based on Gene Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Advanced Therapy Based on Gene Historic Market Size by Application (2018-2023)
3.2.2 Global Advanced Therapy Based on Gene Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Advanced Therapy Based on Gene Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Advanced Therapy Based on Gene Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Advanced Therapy Based on Gene Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Advanced Therapy Based on Gene Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Advanced Therapy Based on Gene Revenue Breakdown by Application (2018-2033)
4 Advanced Therapy Based on Gene Competition Analysis by Players
4.1 Global Advanced Therapy Based on Gene Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
4.3 Date of Key Players Enter into Advanced Therapy Based on Gene Market
4.4 Global Top Players Advanced Therapy Based on Gene Headquarters and Area Served
4.5 Key Players Advanced Therapy Based on Gene Product Solution and Service
4.6 Competitive Status
4.6.1 Advanced Therapy Based on Gene Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biogen
5.1.1 Biogen Profile
5.1.2 Biogen Main Business
5.1.3 Biogen Advanced Therapy Based on Gene Products, Services and Solutions
5.1.4 Biogen Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.1.5 Biogen Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Advanced Therapy Based on Gene Products, Services and Solutions
5.2.4 Novartis Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Gilead Sciences
5.3.1 Gilead Sciences Profile
5.3.2 Gilead Sciences Main Business
5.3.3 Gilead Sciences Advanced Therapy Based on Gene Products, Services and Solutions
5.3.4 Gilead Sciences Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.3.5 Sarepta Therapeutics Recent Developments
5.4 Sarepta Therapeutics
5.4.1 Sarepta Therapeutics Profile
5.4.2 Sarepta Therapeutics Main Business
5.4.3 Sarepta Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
5.4.4 Sarepta Therapeutics Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.4.5 Sarepta Therapeutics Recent Developments
5.5 Alnylam Pharmaceuticals
5.5.1 Alnylam Pharmaceuticals Profile
5.5.2 Alnylam Pharmaceuticals Main Business
5.5.3 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Products, Services and Solutions
5.5.4 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.5.5 Alnylam Pharmaceuticals Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Advanced Therapy Based on Gene Products, Services and Solutions
5.6.4 Amgen Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Spark Therapeutics
5.7.1 Spark Therapeutics Profile
5.7.2 Spark Therapeutics Main Business
5.7.3 Spark Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
5.7.4 Spark Therapeutics Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.7.5 Spark Therapeutics Recent Developments
5.8 Akcea Therapeutics
5.8.1 Akcea Therapeutics Profile
5.8.2 Akcea Therapeutics Main Business
5.8.3 Akcea Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
5.8.4 Akcea Therapeutics Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.8.5 Akcea Therapeutics Recent Developments
5.9 Sunway Biotech
5.9.1 Sunway Biotech Profile
5.9.2 Sunway Biotech Main Business
5.9.3 Sunway Biotech Advanced Therapy Based on Gene Products, Services and Solutions
5.9.4 Sunway Biotech Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.9.5 Sunway Biotech Recent Developments
5.10 SIBIONO
5.10.1 SIBIONO Profile
5.10.2 SIBIONO Main Business
5.10.3 SIBIONO Advanced Therapy Based on Gene Products, Services and Solutions
5.10.4 SIBIONO Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.10.5 SIBIONO Recent Developments
5.11 AnGes
5.11.1 AnGes Profile
5.11.2 AnGes Main Business
5.11.3 AnGes Advanced Therapy Based on Gene Products, Services and Solutions
5.11.4 AnGes Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.11.5 AnGes Recent Developments
5.12 Orchard Therapeutics
5.12.1 Orchard Therapeutics Profile
5.12.2 Orchard Therapeutics Main Business
5.12.3 Orchard Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
5.12.4 Orchard Therapeutics Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.12.5 Orchard Therapeutics Recent Developments
5.13 Human Stem Cells Institute
5.13.1 Human Stem Cells Institute Profile
5.13.2 Human Stem Cells Institute Main Business
5.13.3 Human Stem Cells Institute Advanced Therapy Based on Gene Products, Services and Solutions
5.13.4 Human Stem Cells Institute Advanced Therapy Based on Gene Revenue (US$ Million) & (2018-2023)
5.13.5 Human Stem Cells Institute Recent Developments
6 North America
6.1 North America Advanced Therapy Based on Gene Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Advanced Therapy Based on Gene Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Advanced Therapy Based on Gene Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Advanced Therapy Based on Gene Market Dynamics
11.1 Advanced Therapy Based on Gene Industry Trends
11.2 Advanced Therapy Based on Gene Market Drivers
11.3 Advanced Therapy Based on Gene Market Challenges
11.4 Advanced Therapy Based on Gene Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Advanced Therapy Based on Gene Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Advanced Therapy Based on Gene Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Advanced Therapy Based on Gene Market Size Share by Region (2018-2023)
Table 4. Global Advanced Therapy Based on Gene Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Advanced Therapy Based on Gene Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Advanced Therapy Based on Gene Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Advanced Therapy Based on Gene Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2023)
Table 9. Global Advanced Therapy Based on Gene Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Advanced Therapy Based on Gene Revenue Market Share by Type (2024-2033)
Table 11. North America Advanced Therapy Based on Gene Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Advanced Therapy Based on Gene Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Advanced Therapy Based on Gene Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Advanced Therapy Based on Gene Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Advanced Therapy Based on Gene Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Advanced Therapy Based on Gene Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Advanced Therapy Based on Gene Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Advanced Therapy Based on Gene Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Advanced Therapy Based on Gene Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Advanced Therapy Based on Gene Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Advanced Therapy Based on Gene Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Advanced Therapy Based on Gene Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2023)
Table 24. Global Advanced Therapy Based on Gene Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Advanced Therapy Based on Gene Revenue Market Share by Application (2024-2033)
Table 26. North America Advanced Therapy Based on Gene Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Advanced Therapy Based on Gene Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Advanced Therapy Based on Gene Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Advanced Therapy Based on Gene Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Advanced Therapy Based on Gene Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Advanced Therapy Based on Gene Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Advanced Therapy Based on Gene Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Advanced Therapy Based on Gene Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Advanced Therapy Based on Gene Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Advanced Therapy Based on Gene Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Advanced Therapy Based on Gene Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Advanced Therapy Based on Gene Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
Table 39. Date of Key Players Enter into Advanced Therapy Based on Gene Market
Table 40. Global Advanced Therapy Based on Gene Key Players Headquarters and Area Served
Table 41. Advanced Therapy Based on Gene Product Solution and Service
Table 42. Global Advanced Therapy Based on Gene Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Biogen Basic Information List
Table 45. Biogen Description and Business Overview
Table 46. Biogen Advanced Therapy Based on Gene Products, Services and Solutions
Table 47. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Biogen (2018-2023)
Table 48. Biogen Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Advanced Therapy Based on Gene Products, Services and Solutions
Table 52. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Novartis (2018-2023)
Table 53. Novartis Recent Developments
Table 54. Gilead Sciences Basic Information List
Table 55. Gilead Sciences Description and Business Overview
Table 56. Gilead Sciences Advanced Therapy Based on Gene Products, Services and Solutions
Table 57. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Gilead Sciences (2018-2023)
Table 58. Gilead Sciences Recent Developments
Table 59. Sarepta Therapeutics Basic Information List
Table 60. Sarepta Therapeutics Description and Business Overview
Table 61. Sarepta Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
Table 62. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Sarepta Therapeutics (2018-2023)
Table 63. Sarepta Therapeutics Recent Developments
Table 64. Alnylam Pharmaceuticals Basic Information List
Table 65. Alnylam Pharmaceuticals Description and Business Overview
Table 66. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Products, Services and Solutions
Table 67. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Alnylam Pharmaceuticals (2018-2023)
Table 68. Alnylam Pharmaceuticals Recent Developments
Table 69. Amgen Basic Information List
Table 70. Amgen Description and Business Overview
Table 71. Amgen Advanced Therapy Based on Gene Products, Services and Solutions
Table 72. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Amgen (2018-2023)
Table 73. Amgen Recent Developments
Table 74. Spark Therapeutics Basic Information List
Table 75. Spark Therapeutics Description and Business Overview
Table 76. Spark Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
Table 77. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Spark Therapeutics (2018-2023)
Table 78. Spark Therapeutics Recent Developments
Table 79. Akcea Therapeutics Basic Information List
Table 80. Akcea Therapeutics Description and Business Overview
Table 81. Akcea Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
Table 82. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Akcea Therapeutics (2018-2023)
Table 83. Akcea Therapeutics Recent Developments
Table 84. Sunway Biotech Basic Information List
Table 85. Sunway Biotech Description and Business Overview
Table 86. Sunway Biotech Advanced Therapy Based on Gene Products, Services and Solutions
Table 87. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Sunway Biotech (2018-2023)
Table 88. Sunway Biotech Recent Developments
Table 89. SIBIONO Basic Information List
Table 90. SIBIONO Description and Business Overview
Table 91. SIBIONO Advanced Therapy Based on Gene Products, Services and Solutions
Table 92. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of SIBIONO (2018-2023)
Table 93. SIBIONO Recent Developments
Table 94. AnGes Basic Information List
Table 95. AnGes Description and Business Overview
Table 96. AnGes Advanced Therapy Based on Gene Products, Services and Solutions
Table 97. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of AnGes (2018-2023)
Table 98. AnGes Recent Developments
Table 99. Orchard Therapeutics Basic Information List
Table 100. Orchard Therapeutics Description and Business Overview
Table 101. Orchard Therapeutics Advanced Therapy Based on Gene Products, Services and Solutions
Table 102. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Orchard Therapeutics (2018-2023)
Table 103. Orchard Therapeutics Recent Developments
Table 104. Human Stem Cells Institute Basic Information List
Table 105. Human Stem Cells Institute Description and Business Overview
Table 106. Human Stem Cells Institute Advanced Therapy Based on Gene Products, Services and Solutions
Table 107. Revenue (US$ Million) in Advanced Therapy Based on Gene Business of Human Stem Cells Institute (2018-2023)
Table 108. Human Stem Cells Institute Recent Developments
Table 109. North America Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 110. North America Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 111. Europe Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 112. Europe Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 113. Asia-Pacific Advanced Therapy Based on Gene Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2018-2023) & (US$ Million)
Table 115. Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2024-2033) & (US$ Million)
Table 116. Asia-Pacific Advanced Therapy Based on Gene Market Share by Region (2018-2023)
Table 117. Asia-Pacific Advanced Therapy Based on Gene Market Share by Region (2024-2033)
Table 118. Latin America Advanced Therapy Based on Gene Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 119. Latin America Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 120. Latin America Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 121. Middle East & Africa Advanced Therapy Based on Gene Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 122. Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 123. Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 124. Advanced Therapy Based on Gene Market Trends
Table 125. Advanced Therapy Based on Gene Market Drivers
Table 126. Advanced Therapy Based on Gene Market Challenges
Table 127. Advanced Therapy Based on Gene Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Therapy Based on Gene Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Advanced Therapy Based on Gene Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Advanced Therapy Based on Gene Market Share by Regions: 2022 VS 2033
Figure 4. Global Advanced Therapy Based on Gene Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Advanced Therapy Based on Gene Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Advanced Therapy Based on Gene Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Advanced Therapy Based on Gene Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Advanced Therapy Based on Gene Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Advanced Therapy Based on Gene Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Viral
Figure 11. Global Viral Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Non-viral
Figure 13. Global Non-viral Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Advanced Therapy Based on Gene Market Size Share by Type: 2022 & 2033
Figure 15. North America Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2033)
Figure 16. Europe Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2033)
Figure 20. Neurological Diseases Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Advanced Therapy Based on Gene Market Size Share by Application: 2022 & 2033
Figure 24. North America Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2033)
Figure 25. Europe Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2033)
Figure 29. Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Advanced Therapy Based on Gene Market Share in 2022
Figure 31. North America Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 32. United States Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 35. France Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Advanced Therapy Based on Gene Market Share by Region (2018-2033)
Figure 41. China Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 45. India Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 48. Mexico Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 51. Turkey Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Advanced Therapy Based on Gene Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report